AI Analysis AI Analysis of GMAB AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add GMAB to Watchlist?
Some Reasons Why To Add GMAB:
  • Low bankruptcy risk (Altman Z-Score: 11.40)
  • Consistently positive technical signals over the last month
  • Highly efficient cash conversion (97% FCF/OCF ratio)
PDF

Green day on Friday for Genmab A/S stock after gaining 0.80%
(Updated on Jul 31, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Jul 15, 2026 Loss -0.72%

The Genmab A/S stock price gained 0.80% on the last trading day (Friday, 31st Jul 2026), rising from $28.64 to $28.87. During the last trading day the stock fluctuated 2.46% from a day low at $28.23 to a day high of $28.93. The price has risen in 6 of the last 10 days and is up by 0.52% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 421 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $60.05 million.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 10.97% during the next 3 months and, with a 90% probability hold a price between $28.72 and $33.93 at the end of this 3-month period.

GMAB Signals & Forecast

The Genmab A/S stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $28.84 and $27.61. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, July 20, 2026, and so far it has risen 3.44%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Genmab A/S stock

Genmab A/S finds support from accumulated volume at $28.80 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.695 between high and low, or 2.46%. For the last week the stock has had daily average volatility of 2.04%.

Our recommended stop-loss: $27.36 (-5.22%) (This stock has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 9 days ago.)

Trading Expectations (GMAB) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Genmab A/S to open at $28.68, and during the day (based on 14 day Average True Range), to move between $28.49 and $29.25, which gives a possible trading interval of +/-$0.755 (+/-2.65%) up or down from last closing price. If Genmab A/S takes out the full calculated possible swing range there will be an estimated 2.65% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $28.80 (0.24%) than the resistance at $29.00 (0.45%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

Genmab A/S will release earnings BMO on Thursday, August 06, 2026.The consensus among the analysts for the expected earnings (EPS) is $0.370. We will update the financials statements for Genmab A/S, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 4.34% in the first trading day after earnings release.

Is Genmab A/S stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Genmab A/S stock to perform well in the short-term.

Current score: 1.844 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $28.68 ( 0.675%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

GMAB Performance

Trading levels for GMAB

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 29.37 1.73%
R2 29.10 0.81%
R1 28.94 0.244%
Price 28.87
S1 28.41 -1.60%
S2 28.25 -2.16%
S3 27.98 -3.08%

Accumulated Volume Support & Resistance Levels

Level Price
R3 29.78 3.15%
R2 29.54 2.32%
R1 29.00 0.450%
Price 28.87
S1 28.80 -0.242%
S2 27.21 -5.75%
S3 26.43 -8.45%

FAQ

What is the symbol for Genmab A/S Stock and on which exchange is it traded?
The symbol for Genmab A/S is GMAB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Genmab A/S Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Genmab A/S stock to perform well in the short-term.

How to buy Genmab A/S Stock?
Genmab A/S Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Genmab A/S Stock.

What's the current price of Genmab A/S Stock?
As of the end of day on the Jul 31, 2026, the price of an Genmab A/S (GMAB) share was $28.87.

What is the 52-week high and low for Genmab A/S Stock?
The 52-week high for Genmab A/S Stock is $35.43 and the 52-week low is $21.00.

What is the market capitalization of Genmab A/S Stock?
As of the Jul 31, 2026, the market capitalization of Genmab A/S is 17.724B.

When is the next earnings date for Genmab A/S?
The upcoming earnings date for Genmab A/S is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT GENMAB A/S
Genmab A/S
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphocytic leukemia (CLL) and multiple sclerosis; and Amivantamab for advanced or metastatic gastric or esoph...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE